Pharmaceutical policy in Italy: towards a structural change?

@article{Ghislandi2005PharmaceuticalPI,
  title={Pharmaceutical policy in Italy: towards a structural change?},
  author={Simone Ghislandi and Iva Selke Krulichov{\'a} and Livio Garattini},
  journal={Health policy},
  year={2005},
  volume={72 1},
  pages={53-63}
}
Italian pharmaceutical policy has recently moved towards a "two lanes" approach, with regulation differing according to a drug's patent status. This study analyses the Italian regulatory framework, focusing on policies related to "off-patent" drugs. Three main regulatory innovations have been examined: (i) generics, introduced in Italy for the first time in 1996; (ii) the reference pricing (RP) scheme, under which consumers pay part of the cost of high-priced products; (iii) pharmacists' right… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 15 references

Le nuove modalita’ di distribuzione dei farmaci: l’esperienza dell’APSS di Trento

  • P. Maccani
  • Economia e Politica del Farmaco
  • 2004
1 Excerpt

Generic drugs: regulation and competition in the Italian pharmaceutical industry

  • S. Ghislandi
  • MPhil thesis,
  • 2003
1 Excerpt

Gruppo di studio I . H . A . G . O . Incentivi ai farmaci generici a livello di ASL : l ’ osservatorio I . H . A . G . O

  • S Martina, D Cornago, L Garattini
  • Farmacoeconomia e percorsi terapeutici
  • 2002

Incentivi ai farmaci generici a livello di ASL: l’osservatorio I.H.A.G.O. Farmacoeconomia e percorsi terapeutici 2002;3(2):71–80

  • S Martina, D Cornago
  • 2002
1 Excerpt

Similar Papers

Loading similar papers…